Mendelsohn D. Eric 4
Accession 0001127602-24-023632
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:51 PM ET
Size
37.1 KB
Accession
0001127602-24-023632
Insider Transaction Report
- Exercise/Conversion
Common Stock
2024-09-05$53.41/sh+41,666$2,225,381→ 177,587 total - Tax Payment
Common Stock
2024-09-05$82.10/sh−130,461$10,710,848→ 88,794 total - Exercise/Conversion
Stock Option (Right to Buy) 2023
2024-09-05−13,333→ 0 totalExercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (13,333 underlying) - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-09-05−41,666→ 0 totalExercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (41,666 underlying) - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-09-05−41,668→ 0 totalExercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (41,668 underlying) - Exercise/Conversion
Stock Option (Right to Buy) 2024
2024-09-05−13,333→ 0 totalExercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (13,333 underlying) - Exercise/Conversion
Common Stock
2024-09-05$57.76/sh+13,333$770,114→ 94,255 total - Exercise/Conversion
Stock Option (Right to Buy) 2023
2024-09-05−13,333→ 0 totalExercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (13,333 underlying) - Exercise/Conversion
Common Stock
2024-09-05$53.41/sh+41,666$2,225,381→ 135,921 total - Exercise/Conversion
Common Stock
2024-09-05$54.73/sh+13,333$729,715→ 67,589 total - Exercise/Conversion
Common Stock
2024-09-05$53.41/sh+41,668$2,225,488→ 219,255 total - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-09-05−41,666→ 0 totalExercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (41,666 underlying) - Exercise/Conversion
Common Stock
2024-09-05$54.73/sh+13,333$729,715→ 80,922 total
- 41,666
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2020-02-21Exp: 2025-02-21→ Common Stock (41,666 underlying) - 41,666
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2021-02-21Exp: 2025-02-21→ Common Stock (41,666 underlying) - 41,666
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (41,666 underlying) - 41,666
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (41,666 underlying) - 41,668
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (41,668 underlying) - 13,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (13,334 underlying) - 13,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (13,333 underlying) - 13,334
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (13,334 underlying) - 41,668
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2022-02-21Exp: 2025-02-21→ Common Stock (41,668 underlying)
Footnotes (1)
- [F1]Acquired due to the net exercise of stock options granted 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price and taxes. This transaction was completed subsequent to the execution of a Lock- Up Agreement and shares received are subject to the provisions of that agreement.
Documents
Issuer
NATIONAL HEALTH INVESTORS INC
CIK 0000877860
Related Parties
1- filerCIK 0001410716
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:51 PM ET
- Size
- 37.1 KB